Orthofix Medical Inc.
OFIX
$11.99
$0.121.01%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 6.94% | 1.24% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 6.94% | 1.24% | |||
| Cost of Revenue | 16.64% | -10.19% | |||
| Gross Profit | 3.21% | 6.44% | |||
| SG&A Expenses | -6.87% | 8.29% | |||
| Depreciation & Amortization | -1.86% | -19.42% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.05% | 1.33% | |||
| Operating Income | 83.74% | -2.43% | |||
| Income Before Tax | 90.15% | -56.52% | |||
| Income Tax Expenses | -94.37% | 475.35% | |||
| Earnings from Continuing Operations | 90.25% | -61.88% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 90.25% | -61.88% | |||
| EBIT | 83.74% | -2.43% | |||
| EBITDA | 965.82% | -215.03% | |||
| EPS Basic | 90.30% | -60.79% | |||
| Normalized Basic EPS | 75.67% | -48.42% | |||
| EPS Diluted | 90.02% | -59.22% | |||
| Normalized Diluted EPS | 75.67% | -48.42% | |||
| Average Basic Shares Outstanding | 0.59% | 0.67% | |||
| Average Diluted Shares Outstanding | 0.59% | 0.67% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||